Login
Super Investors / THE ARBITRAGE FUND

THE ARBITRAGE FUND

Arbitrage Funds · net assets $811M · 102 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 77.5% · STIV: 16.5% · DBT: 3.1% · OTHER: 2.4% · DE: 0.6%

Financial position

Total assets
$839M
Total liabilities
$28.3M
Net assets
$811M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$655K

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $45.3M $17.5M $26.3M
Reinvestment $23M $0 $0
Redemptions $12.6M $12.2M $5.59M
Net realized gain (non-derivative) $29.8K $1.24M $9M
Net unrealized appreciation (non-derivative) $3.73M $2.2M $1.6M

The three months of the reporting period, as filed; month 3 ends February 28, 2026.

Filing details

Registrant
Arbitrage Funds
Registrant CIK
1105076
Registrant LEI
549300NPBJYDNFZ58M30
Series
THE ARBITRAGE FUND
Series ID
S000006440
Series LEI
5ID2Z4T6QF54X8TFRS62
SEC file number
811-09815
Address
C/O WATER ISLAND CAPITAL, LLC, 104 FIFTH AVENUE, 9TH FLOOR, NEW YORK, US-NY, 10011, US
Phone
800-560-8210
Form
NPORT-P
Filed
April 28, 2026
Report period ends
May 31, 2026
Report month ends
February 28, 2026
Accession number
000141036826040981
Holding Value % of net assets
Morgan Stanley & Co. LLC STIV $66.2M 8.17%
State Street Global Advisors STIV $66.2M 8.17%
Janus Henderson Group PLC EC $37.3M 4.61%
Electronic Arts Inc EC $32.5M 4.01%
Endeavor Group Holdings Inc EC $32.4M 3.99%
Norfolk Southern Corp EC $31.8M 3.92%
Warner Bros Discovery Inc EC $31.6M 3.89%
Txnm Energy Inc EC $31M 3.83%
Chart Industries Inc EC $30.5M 3.76%
Hologic Inc EC $29.8M 3.67%
Penumbra Inc EC $28.9M 3.56%
Exact Sciences Corp EC $27.6M 3.41%
Water Island Event Driven Fund EC $27M 3.33%
Tegna Inc EC $24.8M 3.06%
Confluent Inc EC $22.4M 2.77%
Morgan Stanley Prime Broker Us OTHER $19.3M 2.38%
Masimo Corp EC $18.2M 2.24%
Schroders PLC EC $18.1M 2.23%
Tri Pointe Homes Inc EC $18.1M 2.23%
Frontier Communications DBT $16.7M 2.05%
Great Lakes Dredge & Dock Corp EC $16.1M 1.98%
Arcellx Inc EC $14.1M 1.74%
Webster Financial Corp EC $14M 1.73%
Digitalbridge Group Inc EC $13.8M 1.70%
Sealed Air Corp EC $13.3M 1.63%
Jde Peet's Nv EC $11.3M 1.40%
Stellar Bancorp Inc EC $11.2M 1.38%
Kenvue Inc EC $10.9M 1.34%
Amicus Therapeutics Inc EC $10.8M 1.33%
Peakstone Realty Trust EC $10M 1.24%
Enhabit Inc EC $8.08M 1.00%
Veris Residential Inc EC $8.06M 0.99%
Kennedy-wilson Holdings Inc EC $8.04M 0.99%
Ventyx Biosciences Inc EC $8.03M 0.99%
Silicon Laboratories Inc EC $8M 0.99%
Zim Integrated Shipping Services Ltd EC $7.93M 0.98%
Chart Industries Inc DBT $7.86M 0.97%
Axalta Coating Systems Ltd EC $6.51M 0.80%
Rapt Therapeutics Inc EC $5.84M 0.72%
Skechers Usa Inc EC $4.26M 0.53%
Clearwater Analytics Holdings Inc EC $4.06M 0.50%
Alexander & Baldwin Inc EC $3.72M 0.46%
Contra Resolute Forest DE $1.2M 0.15%
Bristol-myers Squibb Co DE $965K 0.12%
Contra Albireo Pharma DE $894K 0.11%
Contra Metsera Inc DE $829K 0.10%
Contra Flexion Therape DE $822K 0.10%
Contra Concert Pharmac DE $820K 0.10%
Contra Regulus Therape DE $618K 0.08%
Contra Avadel Pharmace DE $615K 0.08%
Contra Verve Therapeut DE $440K 0.05%
Contra Icosavax Inc DE $301K 0.04%
Contra Abiomed Inc DE $262K 0.03%
Morgan Stanley & Co. LLC DE $236K 0.03%
Atrium Therapeutics Inc EC $193K 0.02%
Contra Treehouse Foods DE $157K 0.02%
Morgan Stanley & Co. LLC DE $142K 0.02%
Contra Akero Therapeut DE $131K 0.02%
Contra Walgreens Boots DE $114K 0.01%
Goldman Sachs & Co. LLC DE $99K 0.01%

Showing top 60 of 102 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support